Attached files

file filename
10-K - 10-K - ACORDA THERAPEUTICS INCreport_annual-123114.htm
EX-21 - LIST OF SUBSIDIARIES - ACORDA THERAPEUTICS INCexhibit_21.htm
EX-31.2 - CFO CERTIFICATION - ACORDA THERAPEUTICS INCexhibit_31-2.htm
EX-32.2 - CFO CERTIFICATION - ACORDA THERAPEUTICS INCexhibit_32-2.htm
EX-31.1 - CEO CERTIFICATION - ACORDA THERAPEUTICS INCexhibit_31-1.htm
EX-32.1 - CEO CERTIFICATION - ACORDA THERAPEUTICS INCexhibit_32-1.htm
EX-10.32 - RESTRICTED STOCK AGREEMENT - ACORDA THERAPEUTICS INCexhibit_10-rsa.htm
EX-10.31 - STOCK OPTION CERTIFICATE - ACORDA THERAPEUTICS INCexhibit_10-option.htm
EX-10.36 - LEASE AGREEMENT - ACORDA THERAPEUTICS INCexhibit_10-lease.htm
EX-10.37 - FIRST LEASE AMENDMENT - ACORDA THERAPEUTICS INCexhibit_10-amend.htm
EX-10.38 - SECOND LEASE AMENDMENT - ACORDA THERAPEUTICS INCexhibit_10-amend2.htm
EX-10.39 - SUBLEASE - ACORDA THERAPEUTICS INCexhibit_10-sublease.htm
EX-10.76 - FIRST APA AMENDMENT - ACORDA THERAPEUTICS INCexhibit_10-alkamend.htm
EX-10.75 - ASSET PURCHASE AGREEMENT - ACORDA THERAPEUTICS INCexhibit_10-alkermes.htm
EX-10.77 - SECOND APA AMENDMENT - ACORDA THERAPEUTICS INCexhibit_10-alkamend2.htm
EXCEL - IDEA: XBRL DOCUMENT - ACORDA THERAPEUTICS INCFinancial_Report.xls
Exhibit 23
 
Consent of Independent Registered Public Accounting Firm
 
The Board of Directors and Stockholders of Acorda Therapeutics, Inc.:

We consent to the incorporation by reference in the following Registration Statements:

(1)  
Registration Statement (Form S-3 No. 333-196803)
 
(2)  
Registration Statement (Form S-8 Nos. 333-194375, 333-164626, 333-158085, 333-131846, 333-149726, 333-174785, 333-179906, and 333-187091)
 
of our reports dated February 27, 2015 with respect to the consolidated financial statements of Acorda Therapeutics, Inc. and the effectiveness of internal control over financial reporting of Acorda Therapeutics, Inc. included in this Annual Report (Form 10-K) of Acorda Therapeutics, Inc. for the year ended December 31, 2014 filed with the Securities and Exchange Commission.
 
 



/s/ Ernst & Young LLP


MetroPark, New Jersey
February 27, 2015